Advances towards licensure of a maternal vaccine for the prevention of invasive group B streptococcus disease in infants: a discussion of different approaches
Group B streptococcus (Streptococcus agalactiae, GBS) is an important cause of life-threatening disease in newborns. Pregnant women colonized with GBS can transmit the bacteria to the developing fetus, as well as to their neonates during or after delivery where infection can lead to sepsis, meningit...
Main Authors: | Judith Absalon, Raphael Simon, David Radley, Peter C. Giardina, Kenneth Koury, Kathrin U. Jansen, Annaliesa S. Anderson |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-01-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2022.2037350 |
Similar Items
-
Novel Multiplex Immunoassays for Quantification of IgG against Group B <italic toggle="yes">Streptococcus</italic> Capsular Polysaccharides in Human Sera
by: Giada Buffi, et al.
Published: (2019-08-01) -
Covering all the bases: Preclinical development of an effective Staphylococcus aureus vaccine
by: Ingrid L Scully, et al.
Published: (2014-03-01) -
Capsular Switching and ICE Transformation Occurred in Human Streptococcus agalactiae ST19 With High Pathogenicity to Fish
by: Rui Wang, et al.
Published: (2018-11-01) -
Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses
by: Siân E. Jossi, et al.
Published: (2023-03-01) -
Development and evaluation of a novel vaccine against prevalent invasive multi-drug resistant strains of Streptococcus pneumoniae
by: Rehab H. Bahy, et al.
Published: (2016-11-01)